Compare RLAY & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | DFIN |
|---|---|---|
| Founded | 2015 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | RLAY | DFIN |
|---|---|---|
| Price | $7.69 | $45.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $16.00 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 2.1M | 231.5K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.12 |
| Revenue | $8,355,000.00 | ★ $750,800,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ N/A | $40.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $37.80 |
| 52 Week High | $8.36 | $69.93 |
| Indicator | RLAY | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 42.22 |
| Support Level | $7.23 | $47.58 |
| Resistance Level | $8.36 | $49.55 |
| Average True Range (ATR) | 0.51 | 1.36 |
| MACD | 0.05 | 0.26 |
| Stochastic Oscillator | 69.18 | 30.59 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.